PATENT CLAIM ANALYSIS

Application Number: 15777102
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "030000"]

Abstract:
The present invention relates to a combination of ivermectin and brimonidine for use in the treatment and/or the prevention of moderate to severe rosacea, preferably by topical administration of a 1% ivermectin cream and 0.33% brimonidine gel.

Claim (Index 5):
Combination for its use according to  claim 1 , wherein ivermectin is present at 1% by total weight of the composition combination and brimonidine is present at 0.33% by total weight of the combination.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 93.0
- Lexical Diversity: 1.28125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14903906', '14257567', '14209927', '14209958', '15699692']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7628789577123395
- 35 USC 102 Novelty (BERT): 0.4751677694584806
- Combined Prediction Score: 0.7341078388869536
- Mean Citation Score: 178.87027400000005
- Max Citation Score: 190.1291
- Similarity Product: 148.52061255868676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test